secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2024-02-06T23:59:59+00:00
Accession:  0000950170-24-011766
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo stockholders approve reverse stock split (1:15-44) and warrant issuance >19.99%
--------------------------------------------------------------------------------

- Proposal 1: 7,159,500 FOR, 2,477,700 AGAINST, 27,721 ABSTAIN; Board has discretion on ratio and timing.
- Proposal 2: 3,977,073 FOR, 1,495,805 AGAINST, 26,255 ABSTAIN; allows immediate exercise of warrants for >19.99% of outstanding shares.
- Reverse split ratio range 1-for-15 to 1-for-44; board will determine final ratio and effective date.
- Warrants: New Series A-2 and New Series B-2; approval under Nasdaq Listing Rule 563(d).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024011766/0000950170-24-011766-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017024011766/apvo-20240205.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-011766

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer